Dr. Edwin Posadas, MD
Claim this profileCedars Sinai Medical Center
Studies Prostate Cancer
Studies Skin Cancer
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Edwin Posadas, MD is currently running
Apalutamide + Carotuximab
for Prostate Cancer
This is an open-label, multi-site study of apalutamide with carotuximab in patients who have progressed on androgen receptor signaling inhibitor (ARSI) therapy. This study will begin with a safety assessment in the first 10 subjects (part 1: Safety Lead-in). If the combination is deemed safe, the trial will proceed to the Phase II stage. The purpose of this study is to compare progression free survival (PFS) between patients receiving apalutamide and apalutamide + carotuximab using Response Evaluation Criteria in Solid Tumors (RECIST 1.1) and Prostate Cancer Working Group 3. The secondary objectives are to describe adverse events related to the intervention, overall response rate (ORR), proportion of patients resistant to apalutamide that benefit from the addition of carotuximab, and to determine the ORR, radiographic PFS, and biochemical PFS in the overall population.
Recruiting1 award Phase 2
Fasting-Mimicking Diet
for Prostate Cancer
This is a Phase 2, randomized two-armed, multi-site study of 138 patients with metastatic castrate sensitive prostate adenocarcinoma. Patients will be randomized 1:1 to receive the fasting mimicking diet, or usual diet. All patients will receive standard of care treatment for their prostate cancer. The fasting mimicking diet will be consumed for 5 days per month for a total of 6 months and will be monitored by trained research dietitians. This study aims to examine the effects of a fasting mimicking diet (5 days per month eating L-Nutra products only for 6 months) vs. usual diet on response to cancer treatment of metastatic castrate sensitive prostate adenocarcinoma.
Recruiting0 awards Phase 2
More about Edwin Posadas, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Edwin Posadas, MD has experience with
- Apalutamide
- Carotuximab
- Enzalutamide
- Radium Ra 223 Dichloride
- Wearable Activity Monitor
- Whole-body Magnetic Resonance Imaging
Breakdown of trials Edwin Posadas, MD has run
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edwin Posadas, MD specialize in?
Edwin Posadas, MD focuses on Prostate Cancer and Skin Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Edwin Posadas, MD currently recruiting for clinical trials?
Yes, Edwin Posadas, MD is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Edwin Posadas, MD has studied deeply?
Yes, Edwin Posadas, MD has studied treatments such as Apalutamide, Carotuximab, Enzalutamide.
What is the best way to schedule an appointment with Edwin Posadas, MD?
Apply for one of the trials that Edwin Posadas, MD is conducting.
What is the office address of Edwin Posadas, MD?
The office of Edwin Posadas, MD is located at: Cedars Sinai Medical Center, Los Angeles, California 90048 United States. This is the address for their practice at the Cedars Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.